Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT05970198
Clinical Trial
Helical Tomotherapy in Multiple Myeloma
Recruiting
View on ClinicalTrials.gov →
Summary
To explore the safety and efficacy of systemic radiotherapy (TBI) combined with melphalan (Mel) for pretreatment of autologous hematopoietic stem cells in multiple myeloma.
Trial Details
NCT Number
NCT05970198
Lead Sponsor
Fuling Zhou
Conditions
Multiple Myeloma
Enrollment
58 participants
Start Date
2023-06-14
Primary Completion
2027-12-31
(estimated)
Study Completion
2027-12-31
(estimated)
Updated on ClinicalTrials.gov
2023-08-01